Clinical Glutathione By EuroMedica Overview & Drug Interactions

Check For Interactions With Clinical Glutathione

Supplement: Clinical Glutathione by EuroMedica

Clinical Glutathione Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Clinical Glutathione by EuroMedica

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Clinical Glutathione. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Clinical Glutathione interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Slow Melt Tablet(s)
Maximum serving Sizes:
2 Slow Melt Tablet(s)
Servings per container 30
UPC/BARCODE 367703737061

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
L-Glutathione
300 mg
Gluthathione --

Other Ingredients:
Maltitol
Hydroxypropyl Methylcellulose
Pomegranate (Punica granatum) fruit extract
Vanilla flavor
Vegetable Source Magnesium Stearate
Stevia


Label Statments:


Formulation
- Proven active form
- 230% greater blood ratios
- Proven stability 230% improvement
- Vegan
- Non-GMO
- In a published human study, Clinical Glutathione with Sublinthion reported a 230% improvement in healthy glutathione ratios compared to unprotected glutathione.
- No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.
Brand IP Statement(s)
- Sublinthion Patented protection system
- French patent #FR2972327
Formula
- Patented, reduced oral glutathione for vital support
FDA Statement of Identity
- Dietary Supplement
FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
- Product of France
- Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation. Blood GSH/GSSG ratio compared to unprotected glutathione
Suggested/Recommended/Usage/Directions
- Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.
Precautions
- If pregnant or nursing, consult a healthcare practitioner before using.

Brand Information

See all products by this brand

Manufactured by a cGMP compliant facility exclusively for
Name EuroMedica
Street Address 955 Challenger Drive
City Green Bay
State WI
ZipCode 54311
Phone Number 866-842-7256
Email EuroMedicaUSA.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.